Dr Donaye Allyn Blake, PHARM D | |
9325 Parkway E, Birmingham, AL 35215-8303 | |
(205) 833-6882 | |
Not Available |
Full Name | Dr Donaye Allyn Blake |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 9325 Parkway E, Birmingham, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316214596 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 15643 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Donaye Allyn Blake, PHARM D 6194 Bent Brook Dr, Bessemer, AL 35022-6702 Ph: (205) 919-3024 | Dr Donaye Allyn Blake, PHARM D 9325 Parkway E, Birmingham, AL 35215-8303 Ph: (205) 833-6882 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that top-line data from part one of a two-part Phase 1 study of SPI-1620 in combination with docetaxel was presented in an oral presentation at the 12th International Conference on Endothelin, held in Cambridge, United Kingdom, from September 11-14, 2011. Part one of the study has been completed, while part two is ongoing.
Scientists may have discovered more reasons to love chocolate. A new study by researchers at the University of Illinois suggests that three of the phenolic compounds in cocoa bean shells have powerful effects on the fat and immune cells in mice, potentially reversing the chronic inflammation and insulin resistance associated with obesity.
In an effort to ensure that student health plays a central role in California's education reform agenda, the state's largest private health foundation today unveiled the first report produced from a multi-year project addressing the connection between student health and academic achievement.
Heart failure and cancer are conditions with a number of shared characteristics. A new study published in the Journal of Internal Medicine found that in patients with heart failure, several known tumor markers can also be indicators of heart failure severity and progression.
People with type 1 diabetes are at high risk of developing kidney disease, but no therapies are proven to prevent impaired kidney function in these patients. In the Diabetes Control and Complications Trial (DCCT), Ian de Boer, MD and his team looked to see if intensive diabetes therapy aimed at reducing blood sugar as close to the normal range as possible might protect type 1 diabetics' kidney function. The study's results were presented during the American Society of Nephrology's Annual Kidney Week.
› Verified 9 days ago
Katerina Elaine Pappas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4616 Highway 280, Birmingham, AL 35242 Phone: 205-991-6248 | |
Lindsey Elmore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Lakeshore Dr, Birmingham, AL 35229 Phone: 205-726-4431 | |
Ms. Debra Mcconnell Larussa, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 Center Point Pkwy, Birmingham, AL 35215 Phone: 205-852-8001 Fax: 205-852-6879 | |
Dr. Joshua James Tessin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5350 | |
James Andrew Carr, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 19th Street South, Birmingham, AL 35233 Phone: 205-933-8101 Fax: 205-558-4784 | |
Betty A Morris, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5511 Highway 280, Suite 301, Birmingham, AL 35242 Phone: 205-995-8388 Fax: 205-995-8897 | |
Leanne Phillips, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Medical Park Dr E, Birmingham, AL 35235 Phone: 205-915-1011 |